Vanguard Personalized Indexing Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,176
| Closed | -$394K | – | 2030 |
|
|
2025
Q1 | $394K | Sell |
6,176
-1,532
| -20% | -$97.8K | 0.01% | 1223 |
|
|
2024
Q4 | $937K | Buy |
7,708
+1,919
| +33% | +$233K | 0.01% | 801 |
|
|
2024
Q3 | $723K | Buy |
5,789
+1,284
| +29% | +$160K | 0.01% | 921 |
|
|
2024
Q2 | $712K | Buy |
4,505
+479
| +12% | +$75.7K | 0.01% | 849 |
|
|
2024
Q1 | $521K | Buy |
4,026
+365
| +10% | +$47.3K | 0.01% | 1002 |
|
|
2023
Q4 | $353K | Sell |
3,661
-2,469
| -40% | -$238K | 0.01% | 1164 |
|
|
2023
Q3 | $743K | Sell |
6,130
-30
| -0.5% | -$3.64K | 0.02% | 710 |
|
|
2023
Q2 | $705K | Sell |
6,160
-111
| -2% | -$12.7K | 0.02% | 745 |
|
|
2023
Q1 | $864K | Sell |
6,271
-125
| -2% | -$17.2K | 0.03% | 602 |
|
|
2022
Q4 | $829K | Buy |
6,396
+518
| +9% | +$67.1K | 0.03% | 582 |
|
|
2022
Q3 | $650K | Buy |
5,878
+69
| +1% | +$7.63K | 0.03% | 675 |
|
|
2022
Q2 | $435K | Sell |
5,809
-2,023
| -26% | -$151K | 0.02% | 864 |
|
|
2022
Q1 | $612K | Sell |
7,832
-2,945
| -27% | -$230K | 0.03% | 728 |
|
|
2021
Q4 | $970K | Buy |
+10,777
| New | +$970K | 0.06% | 408 |
|